Cargando…
Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients
Although dogma predicts that under normal circumstances, potentially offensive autoreactive cells are silenced by mechanisms of immune tolerance, islet antigen–reactive B lymphocytes are known to play a crucial role in the development of autoimmunity in type 1 diabetes (T1D). Thus, participation of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407867/ https://www.ncbi.nlm.nih.gov/pubmed/25524915 http://dx.doi.org/10.2337/db13-1798 |
_version_ | 1782367972557324288 |
---|---|
author | Smith, Mia J. Packard, Thomas A. O’Neill, Shannon K. Henry Dunand, Carole J. Huang, Min Fitzgerald-Miller, Lisa Stowell, Daniel Hinman, Rochelle M. Wilson, Patrick C. Gottlieb, Peter A. Cambier, John C. |
author_facet | Smith, Mia J. Packard, Thomas A. O’Neill, Shannon K. Henry Dunand, Carole J. Huang, Min Fitzgerald-Miller, Lisa Stowell, Daniel Hinman, Rochelle M. Wilson, Patrick C. Gottlieb, Peter A. Cambier, John C. |
author_sort | Smith, Mia J. |
collection | PubMed |
description | Although dogma predicts that under normal circumstances, potentially offensive autoreactive cells are silenced by mechanisms of immune tolerance, islet antigen–reactive B lymphocytes are known to play a crucial role in the development of autoimmunity in type 1 diabetes (T1D). Thus, participation of these cells in T1D may reflect escape from silencing mechanisms. Consistent with this concept, we found that in healthy subjects, high-affinity insulin-binding B cells occur exclusively in the anergic naive IgD(+), IgM(−) B-cell (B(ND)) compartment. Antigen receptors expressed by these cells are polyreactive and have N-region additions, Vh usage, and charged complementarity-determining region 3 consistent with autoreactivity. Consistent with a potential early role in autoimmunity, these high-affinity insulin-binding B cells are absent from the anergic compartment of some first-degree relatives and all prediabetic and new-onset (<1 year) T1D patients tested, but return to normal levels in individuals diabetic for >1 year. Interestingly, these changes were correlated by transient loss of the entire B(ND) compartment. These findings suggest that environmental events such as infection or injury may, by disrupting B-cell anergy, dispose individuals toward autoimmunity, the precise nature of which is specified by genetic risk factors, such as HLA alleles. |
format | Online Article Text |
id | pubmed-4407867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-44078672016-05-01 Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients Smith, Mia J. Packard, Thomas A. O’Neill, Shannon K. Henry Dunand, Carole J. Huang, Min Fitzgerald-Miller, Lisa Stowell, Daniel Hinman, Rochelle M. Wilson, Patrick C. Gottlieb, Peter A. Cambier, John C. Diabetes Immunology and Transplantation Although dogma predicts that under normal circumstances, potentially offensive autoreactive cells are silenced by mechanisms of immune tolerance, islet antigen–reactive B lymphocytes are known to play a crucial role in the development of autoimmunity in type 1 diabetes (T1D). Thus, participation of these cells in T1D may reflect escape from silencing mechanisms. Consistent with this concept, we found that in healthy subjects, high-affinity insulin-binding B cells occur exclusively in the anergic naive IgD(+), IgM(−) B-cell (B(ND)) compartment. Antigen receptors expressed by these cells are polyreactive and have N-region additions, Vh usage, and charged complementarity-determining region 3 consistent with autoreactivity. Consistent with a potential early role in autoimmunity, these high-affinity insulin-binding B cells are absent from the anergic compartment of some first-degree relatives and all prediabetic and new-onset (<1 year) T1D patients tested, but return to normal levels in individuals diabetic for >1 year. Interestingly, these changes were correlated by transient loss of the entire B(ND) compartment. These findings suggest that environmental events such as infection or injury may, by disrupting B-cell anergy, dispose individuals toward autoimmunity, the precise nature of which is specified by genetic risk factors, such as HLA alleles. American Diabetes Association 2015-05 2014-12-18 /pmc/articles/PMC4407867/ /pubmed/25524915 http://dx.doi.org/10.2337/db13-1798 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
spellingShingle | Immunology and Transplantation Smith, Mia J. Packard, Thomas A. O’Neill, Shannon K. Henry Dunand, Carole J. Huang, Min Fitzgerald-Miller, Lisa Stowell, Daniel Hinman, Rochelle M. Wilson, Patrick C. Gottlieb, Peter A. Cambier, John C. Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title | Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title_full | Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title_fullStr | Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title_full_unstemmed | Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title_short | Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients |
title_sort | loss of anergic b cells in prediabetic and new-onset type 1 diabetic patients |
topic | Immunology and Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407867/ https://www.ncbi.nlm.nih.gov/pubmed/25524915 http://dx.doi.org/10.2337/db13-1798 |
work_keys_str_mv | AT smithmiaj lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT packardthomasa lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT oneillshannonk lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT henrydunandcarolej lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT huangmin lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT fitzgeraldmillerlisa lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT stowelldaniel lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT hinmanrochellem lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT wilsonpatrickc lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT gottliebpetera lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients AT cambierjohnc lossofanergicbcellsinprediabeticandnewonsettype1diabeticpatients |